Targeting LILRB4 with car-T or car-NK cells in the treatment of cancer

• 收藏
• 分享

专利权人:

The Board of Regents of the University of Texas System

发明人:

ZHANG, Chengcheng,JOHN, Samuel,CHEN, Heyu,DENG, Mi,GUI, Xun,ZHANG, Ningyan,AN, Zhiqiang

申请号：

AU2018365880

公开号：

AU2018365880A1

申请日:

2018.11.06

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present disclosure provides methods and compositions for immunotherapy employing a modified T cell or NK cell comprising a chimeric LILRB4 antigen receptor (CAR) that can be administered to patients for disease (

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/